Gemox Chemotherapy
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Adebrelimab and a TKI in Combination With GEMOX in First-line Treatment of Advanced Biliary Tract Cancers (BTC) (NCT06320301) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2024-04-01 |
| Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors (NCT04669496) | Shanghai Zhongshan Hospital | 2021-01-20 |
Track Gemox Chemotherapy automatically
Every clearance here is in the API, with alerts when new ones post.